| Setting up a technology commercialization office at a non-entrepreneurial university: An insider’s look at practices and culture K Sideri, A Panagopoulos The Journal of Technology Transfer 43, 953-965, 2018 | 27 | 2018 |
| Remote digital monitoring of medication intake: methodological, medical, ethical and legal reflections W Van Biesen, J Decruyenaere, K Sideri, J Cockbain, S Sterckx Acta Clinica Belgica 76 (3), 209-216, 2021 | 21 | 2021 |
| Law's practical wisdom: the theory and practice of law making in new governance structures in the European Union K Sideri Routledge, 2017 | 15 | 2017 |
| Questioning the neutrality of procedural law: Internet regulation in Europe through the lenses of Bourdieu's notion of symbolic capital K Sideri European Law Journal 10 (1), 61-86, 2004 | 15 | 2004 |
| Incentivizing the sharing of healthcare data in the AI Era A Panagopoulos, T Minssen, K Sideri, H Yu, MC Compagnucci Computer Law & Security Review 45, 105670, 2022 | 14 | 2022 |
| Prospect patents and CRISPR; rivalry and ethical licensing in a semi-commons environment A Panagopoulos, K Sideri Journal of Law and the Biosciences 8 (2), lsab031, 2021 | 10 | 2021 |
| Bioproperty, biomedicine and deliberative governance: patents as discourse on life K Sideri Routledge, 2016 | 10 | 2016 |
| COVID-19 contact tracing apps and the governance of collective action: social nudges, deliberation, and solidarity in Europe and beyond K Sideri, B Prainsack Policy Studies 44 (1), 132-153, 2023 | 8 | 2023 |
| The European Commission and the law-making process: compromise as a category of praxis? K Sideri Cambridge University Press, 2005 | 6 | 2005 |
| Prospect patents, data markets, and the commons in data-driven medicine: Openness and the political economy of intellectual property rights K Sideri Science and Public Policy 47 (5), 668-677, 2020 | 3 | 2020 |
| Practical Reasoning, Impartiality and the E uropean P atent O ffice: The Legal Regulation of Biotechnology K Sideri European Law Journal 18 (6), 821-843, 2012 | 3 | 2012 |
| Openness, innovation, and science policy in the age of data-driven medicine G Dutfield, K Sideri Science and Public Policy, scaa009, 2020 | 2 | 2020 |
| Germline modification of human embryos, patents and the limits of markets: Rethinking Equality, human diversity and the question of innovation funding K Sideri Cambridge University Press, https://www. researchgate. net/publication/323700952, 2018 | 2 | 2018 |
| Elements of a Theory of Law Making In the European Union K Sideri Law's Practical Wisdom, 2017 | 2 | 2017 |
| Digital pills for the remote monitoring of medication intake: a stakeholder analysis and assessment of marketing approval and patent granting policies SS Katerina Sideri, Julian Cockbain, Wim Van Biesen, Marc De Hert, Johan ... Journal of Law and the Biosciences 9 (2), 2022 | 1 | 2022 |
| Patent Politics: Life Forms, Markets and the Public Interest in the United States and Europe by Shobita Parthasarathy K Sideri Technology and Culture 59 (3), 817-818, 2018 | 1 | 2018 |
| Health, Global Justice, and Virtue Bioethics K Sideri | 1 | 2008 |
| From lab to mass production; a policy for enabling the licensing of mRNA vaccines PANAGOPOULOS A., SIDERI K. Frontiers in Public Health https://www.frontiersin.org/articles/10.3389 …, 2023 | | 2023 |
| Resource allocation in genetic and genomic medicine J Buchanan, I Goranitis, I Slade, A Kerasidou, M Sheehan, K Sideri, ... Journal of Community Genetics 13 (5), 463-466, 2022 | | 2022 |
| Bioproperty, biomedicine and deliberative governance: patents as discourse on life: by Katherina Sideri, Farnham, Ashgate, 2014, 196 pp.,£ 65 (hardback), ISBN 9780754677383 G De Michele New Genetics and Society 38 (4), 464-465, 2019 | | 2019 |
